XOMA Profit Margin 2006-2021 | XOMA
Current and historical gross margin, operating margin and net profit margin for XOMA (XOMA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. XOMA net profit margin as of September 30, 2021 is 4.63%.
|XOMA Annual Profit Margins
|XOMA Quarterly Profit Margins
||Medical - Biomedical and Genetics
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.